PR Newswire: BioDelivery Sciences International Secures $20 Million in Debt Financing

A company to keep a look out for in the upcoming future is BioDelivery Sciences International (BDSI), a specialty pharmaceutical company with a platform of drug delivery technologies to develop, commercialize, and improve already proven applications of therapeutics.

Read more »